Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice

Publisher： Karger

E-ISSN： 1660-2862|6|1-2|29-36

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.6, Iss.1-2, 2008-11, pp. : 29-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SOD-1 inhibits FAS expression in cortex of APP transgenic mice

By Chen Z.  

Apoptosis, Vol. 10, Iss. 3, 2005-05 ,pp. : 499-502

Springer Publishing Company

Access to resources Recommend Favorite

Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 157-159

Karger

Access to resources Recommend Favorite

Human Recombinant Butyrylcholinesterase Purified from the Milk of Transgenic Goats Interacts with Beta-Amyloid Fibrils and Suppresses Their Formation in vitro

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 232-236

Karger

Access to resources Recommend Favorite

Early effects of aluminum chloride on beta-secretase mRNA expression in a neuronal model of ß-amyloid toxicity

By Castorina Alessandro   Tiralongo Adriana   Giunta Salvatore   Carnazza Maria   Scapagnini Giovanni   D’Agata Velia  

Cell Biology and Toxicology, Vol. 26, Iss. 4, 2010-08 ,pp. : 367-377

Springer Publishing Company

Access to resources Recommend Favorite

Intraneuronal β-Amyloid Is a Major Risk Factor – Novel Evidence from the APP/PS1KI Mouse Model

By  

Neurodegenerative Diseases, Vol. 5, Iss. 3-4, 2008-03 ,pp. : 140-142

Karger

Access to resources Recommend Favorite